Antacid Market 2019-2025
|発行||Orion Market Research Pvt Ltd||商品コード||911648|
Market Size, Share & Trends Analysis Report by Drug Class (Proton Pump Inhibitor, H2 Antagonist, and Acid Neutralizers) and by Formulation Type (Tablet, Liquid, and Powder) and Forecast, 2019-2025.
The global antacid market is projected to register significant growth during the forecast period. Antacids are the class of drugs that are used to cure acid reflux that causes heartburns and acidity. The growth of the antacid market is expected to grow on the backdrop of the growing geriatric population suffering from gastroesophageal reflux disease (GERD). The widespread practice of self-medication among the population suffering from acidity and heartburns is a major factor propelling the market growth across the globe. Availability of antacids on various packaging formats such as ready-to-drink, sachet format, and many other formats serves the purpose of ease of use and increases the shelf-life of the product.
The antacid market is segmented on the basis of drug class and formulation type. Based on drug class, the market is segmented into a proton pump inhibitor, H2 antagonist, and acid neutralizers. Among these drug classes, the proton pump inhibitors are expected to register considerable growth in the market during the forecast period as the various proton pump inhibitors work for heartburns that are not resolved by acid neutralizers and h2 antagonist. Moreover, proton pump inhibitors the preferred solutions for consumers suffering from chronic heartburn. Based on formulation types, the market is segmented into tablet, liquid, and powder. Tablet segment is expected to register significant growth in the market during the forecast period, owing to the availability of chewing tablet in various flavors that adheres the consumers to medication. Moreover, tablets offer the right amount of dosage as compared to other types of formulation.
Geographically, the global antacid market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America holds a significant share in the global antacid market, owing to the rising prevalence of the digestive disease in the region. A sedentary lifestyle coupled with unhealthy dietary habits and less of physical activity are some of the key factors pointed towards the rising gastric diseases in the region, which in turn, increases the adoption rate of antacids in North America.
The major players operating in the global antacid market include GlaxoSmithKline PLC, Abbott Laboratories, Reckitt Benckiser Group PLC, Bayer AG, Sanofi SA, Pfizer Inc., and The Procter & Gamble Co. to outreach the customer base, many companies are adopting the strategies of acquisitions, mergers, and product launch. For instance, in April 2017, Piramal Enterprises has launched the 'Paan' flavored 'Polycrol', the company's antacid brand. The polycrol offers the consumer a pleasant after-taste while offering relief from acidity.
The market study of the global antacid market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.
The report is intended for healthcare and pharmaceuticals providers for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.